Nanostructures for the Inhibition of Viral Infections

Anti-HIV Drug-Combination Nanoparticles Enhance Plasma Drug Exposure Duration as Well as Triple-Drug Combination Levels in Cells Within Lymph Nodes and Blood in Primates

(2015) Jennifer P. Freeling et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes

(2015) Daniela Iannazzo et al.   CARBON

Boronic acid-modified lipid nanocapsules: a novel platform for the highly efficient inhibition of hepatitis C viral entry

(2015) Manakamana Khanal et al.   Nanoscale

Aquareovirus NS80 Initiates Efficient Viral Replication by Retaining Core Proteins within Replication-Associated Viral Inclusion Bodies

(2015) Liming Yan et al.   PLoS One

The potential of nanoparticles for the immunization against viral infections

(2015) Viktoriya Sokolova et al.   Journal of Materials Chemistry B

Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects

(2014) Mahendra Rai et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Glycosystems in nanotechnology: Gold glyconanoparticles as carrier for anti-HIV prodrugs

(2014) Fabrizio Chiodo et al.   Beilstein Journal of Organic Chemistry

Tannic Acid Modified Silver Nanoparticles Show Antiviral Activity in Herpes Simplex Virus Type 2 Infection

(2014) Piotr Orlowski et al.   PLoS One

Preparation and Evaluation of NovelIn SituGels Containing Acyclovir for the Treatment of Oral Herpes Simplex Virus Infections

(2014) Binu Chaudhary et al.   TheScientificWorldJOURNAL

Lipid Nanoparticles as Carriers for RNAi against Viral Infections: Current Status and Future Perspectives

(2014) Josune Torrecilla et al.   Biomed Research International

Enhanced Oral Bioavailability of Efavirenz by Solid Lipid Nanoparticles:In VitroDrug Release and Pharmacokinetics Studies

(2014) Praveen Kumar Gaur et al.   Biomed Research International

Current prodrug strategies for improving oral absorption of nucleoside analogues

(2014) Youxi Zhang et al.   Asian Journal of Pharmaceutical Sciences

Phenylboronic-Acid-Modified Nanoparticles: Potential Antiviral Therapeutics

(2013) Manakamana Khanal et al.   ACS Applied Materials & Interfaces

Cell Membranes Open “Doors” for Cationic Nanoparticles/Biomolecules: Insights into Uptake Kinetics

(2013) Jiaqi Lin et al.   ACS Nano

A review of nanotechnological approaches for the prophylaxis of HIV/AIDS

(2013) Abhijit A. Date et al.   BIOMATERIALS

Binding sugars: from natural lectins to synthetic receptors and engineered neolectins

(2013) Julie Arnaud et al.   CHEMICAL SOCIETY REVIEWS

Glyconanoparticles as multifunctional and multimodal carbohydrate systems

(2013) Marco Marradi et al.   CHEMICAL SOCIETY REVIEWS

Evaluation of microporous polycaprolactone matrices for controlled delivery of antiviral microbicides to the female genital tract

(2013) Naghme Hajarol Asvadi et al.   JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

Drug Synergy of Tenofovir and Nanoparticle-Based Antiretrovirals for HIV Prophylaxis

(2013) Thanyanan Chaowanachan et al.   PLoS One

Altering cell death pathways as an approach to cure HIV infection

(2013) A D Badley et al.   Cell Death & Disease

Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice

(2013) Sabrina Valetti et al.   JOURNAL OF NANOBIOTECHNOLOGY

Microemulsion-Based Oxyresveratrol for Topical Treatment of Herpes Simplex Virus (HSV) Infection: Physicochemical Properties and Efficacy in Cutaneous HSV-1 Infection in Mice

(2012) Pattaraporn Sasivimolphan et al.   AAPS PHARMSCITECH

Hyaluronic Acid–Gold Nanoparticle/Interferon α Complex for Targeted Treatment of Hepatitis C Virus Infection

(2012) Min-Young Lee et al.   ACS Nano

Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection

(2012) Thessicar E. Antoine et al.   ANTIVIRAL RESEARCH

New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets

(2012) Alexander Ploss et al.   GUT

Colloidal dispersions for the delivery of acyclovir: A comparative study

(2012) Rita Cortesi et al.   INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES

Anti-HIV-1 nanotherapeutics: promises and challenges for the future

(2012) Supriya Mahajan et al.   International Journal of Nanomedicine

Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy

(2012) David Lembo et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection

(2012) Jill M. Steinbach et al.   JOURNAL OF CONTROLLED RELEASE

Inhibition of Hepatitis C Virus Replication by Intracellular Delivery of Multiple siRNAs by Nanosomes

(2012) Partha K Chandra et al.   MOLECULAR THERAPY

Surface-Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 Treatment

(2012) Ligeng Xu et al.   NANO LETTERS

Nanomedicine applications towards the cure of HIV

(2012) Julianna Lisziewicz et al.   Nanomedicine-Nanotechnology Biology and Medicine

A simple and accessible synthetic lectin for glucose recognition and sensing

(2012) Chenfeng Ke et al.   Nature Chemistry

Nanoparticle-based artificial RNA silencing machinery for antiviral therapy

(2012) Z. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nanotechnology and the Treatment of HIV Infection

(2012) Raveen Parboosing et al.   Viruses-Basel

New developments and opportunities in oral mucosal drug delivery for local and systemic disease

(2011) Vanessa Hearnden et al.   ADVANCED DRUG DELIVERY REVIEWS

Griffithsin Has Antiviral Activity against Hepatitis C Virus

(2011) Philip Meuleman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Virostatic potential of micro–nano filopodia-like ZnO structures against herpes simplex virus-1

(2011) Yogendra Kumar Mishra et al.   ANTIVIRAL RESEARCH

Functional delivery of DNAzyme with iron oxide nanoparticles for hepatitis C virus gene knockdown

(2011) Soo-Ryoon Ryoo et al.   BIOMATERIALS

A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo

(2011) Philip Meuleman et al.   HEPATOLOGY

Anti-heparan Sulfate Peptides That Block Herpes Simplex Virus Infectionin Vivo

(2011) Vaibhav Tiwari et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The cell biology of receptor-mediated virus entry

(2011) Joe Grove et al.   JOURNAL OF CELL BIOLOGY

Systemic Administration of Combinatorial dsiRNAs via Nanoparticles Efficiently Suppresses HIV-1 Infection in Humanized Mice

(2011) Jiehua Zhou et al.   MOLECULAR THERAPY

Structure and biological activity of pathogen-like synthetic nanomedicines

(2011) Orsolya Lőrincz et al.   Nanomedicine-Nanotechnology Biology and Medicine

Fusing structure and function: a structural view of the herpesvirus entry machinery

(2011) Sarah A. Connolly et al.   NATURE REVIEWS MICROBIOLOGY

Boronic Acid Functionalized Peptidyl Synthetic Lectins: Combinatorial Library Design, Peptide Sequencing, and Selective Glycoprotein Recognition

(2011) Kevin L. Bicker et al.   ACS Combinatorial Science

Design, Synthesis, and Screening of a Library of Peptidyl Bis(Boroxoles) as Oligosaccharide Receptors in Water: Identification of a Receptor for the Tumor Marker TF-Antigen Disaccharide

(2010) Arnab Pal et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management

(2010) Jocelyne Piret et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents

(2010) Paolo Di Gianvincenzo et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Skin irritation and the inhibition effect on HSV-1 in vivo of penciclovir-loaded microemulsion

(2010) Aihua Yu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors

(2010) Andrew J. Syder et al.   JOURNAL OF HEPATOLOGY

Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies

(2010) Mirjam B. Zeisel et al.   JOURNAL OF HEPATOLOGY

Emerging nanotechnology approaches for HIV/AIDS treatment and prevention

(2010) Tewodros Mamo et al.   Nanomedicine

Inhibition of HSV-1 Attachment, Entry, and Cell-to-Cell Spread by Functionalized Multivalent Gold Nanoparticles

(2010) Dana Baram-Pinto et al.   Small

Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus Macaques with RT-SHIV

(2010) Mélanie Caron et al.   VIROLOGY

A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry

(2010) Carl J. Baldick et al.   PLoS Pathogens

Development of Novel Microemulsion-Based Topical Formulations of Acyclovir for the Treatment of Cutaneous Herpetic Infections

(2009)   Shishu et al.   AAPS PHARMSCITECH

A Synthetic Lectin for β-Glucosyl

(2009) Nicholas P. Barwell et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Inhibition of Herpes Simplex Virus Type 1 Infection by Silver Nanoparticles Capped with Mercaptoethane Sulfonate

(2009) Dana Baram-Pinto et al.   BIOCONJUGATE CHEMISTRY

Combination antiretroviral drugs in PLGA nanoparticle for HIV-1

(2009) Christopher J Destache et al.   BMC INFECTIOUS DISEASES

Durable Protection from Herpes Simplex Virus-2 Transmission Following Intravaginal Application of siRNAs Targeting Both a Viral and Host Gene

(2009) Yichao Wu et al.   Cell Host & Microbe

Multivalent Manno-Glyconanoparticles Inhibit DC-SIGN-Mediated HIV-1 Trans-Infection of Human T Cells

(2009) Olga Martínez-Ávila et al.   CHEMBIOCHEM

Microbicides and HIV prevention: lessons from the past, looking to the future

(2009) Georgina C Morris et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry

(2009) Jihan Akhtar et al.   FEBS Journal

Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection

(2009) Christoph Sarrazin et al.   GASTROENTEROLOGY

A synthetic CD4–heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry

(2009) Françoise Baleux et al.   Nature Chemical Biology

Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA

(2009) Kim A. Woodrow et al.   NATURE MATERIALS

5′-O-D-ValylaraA, A Potential Prodrug for Improving Oral Bioavailability of the Antiviral Agent Vidarabine

(2009) Wei Shen et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo

(2008) Philip Meuleman et al.   HEPATOLOGY

Formulation design of microemulsion for dermal delivery of penciclovir

(2008) Weiwei Zhu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes

(2008) Soo In Kim et al.   JOURNAL OF HEPATOLOGY

Inhibition of HIV Fusion with Multivalent Gold Nanoparticles

(2008) Mary-Catherine Bowman et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Targeted Delivery of PSC-RANTES for HIV-1 Prevention using Biodegradable Nanoparticles

(2008) Anthony S. Ham et al.   PHARMACEUTICAL RESEARCH

Methods for the Preparation and Manufacture of Polymeric Nanoparticles

(2008) Christine Vauthier et al.   PHARMACEUTICAL RESEARCH